Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates
Top Cited Papers
Open Access
- 4 March 2010
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 27 (5), 796-810
- https://doi.org/10.1007/s11095-010-0073-2
Abstract
Purpose To evaluate the nanoparticle tracking analysis (NTA) technique, compare it with dynamic light scattering (DLS) and test its performance in characterizing drug delivery nanoparticles and protein aggregates. Methods Standard polystyrene beads of sizes ranging from 60 to 1,000 nm and physical mixtures thereof were analyzed with NTA and DLS. The influence of different ratios of particle populations was tested. Drug delivery nanoparticles and protein aggregates were analyzed by NTA and DLS. Live monitoring of heat-induced protein aggregation was performed with NTA. Results NTA was shown to accurately analyze the size distribution of monodisperse and polydisperse samples. Sample visualization and individual particle tracking are features that enable a thorough size distribution analysis. The presence of small amounts of large (1,000 nm) particles generally does not compromise the accuracy of NTA measurements, and a broad range of population ratios can easily be detected and accurately sized. NTA proved to be suitable to characterize drug delivery nanoparticles and protein aggregates, complementing DLS. Live monitoring of heat-induced protein aggregation provides information about aggregation kinetics and size of submicron aggregates. Conclusion NTA is a powerful characterization technique that complements DLS and is particularly valuable for analyzing polydisperse nanosized particles and protein aggregates.Keywords
This publication has 18 references indexed in Scilit:
- Protein aggregation: Pathways, induction factors and analysisJournal of Pharmaceutical Sciences, 2009
- Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccinationJournal of Controlled Release, 2009
- Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product QualityJournal of Pharmaceutical Sciences, 2009
- Response of a concentrated monoclonal antibody formulation to high shearBiotechnology & Bioengineering, 2009
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Protein drug stability: a formulation challengeNature Reviews Drug Discovery, 2005
- Induction and analysis of aggregates in a liquid IgG1-antibody formulationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Asymmetrical Flow Field-Flow Fractionation and Multiangle Light Scattering for Analysis of Gelatin Nanoparticle Drug Carrier SystemsAnalytical Chemistry, 2004
- Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- Bioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery, 2002